跳至主要内容
临床试验/NCT00624715
NCT00624715已完成1 期

Cannabinoid Receptor Function & Alcoholism: Effects of Δ-9-THC

Yale University1 个研究点 分布在 1 个国家目标入组 29 人开始时间: 2007年8月9日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
29
试验地点
1
主要终点
Clinician Administered Dissociative Symptoms Scale, Visual Analog Scale ("High" rating), Rey Auditory Verbal Learning Test

研究概览

简要总结

This study attempts to characterize the effects of tetrahydrocannabinol (THC). Tetrahydrocannabinol is the active ingredient of marijuana, cannabis, "ganja", or "pot". This study will involve healthy volunteers who 1) have no history of alcoholism in their family or 2) have a family history of alcoholism. This study looks at individuals with or without a family history of alcoholism to determine if there is a difference between the two groups in the response to THC.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Exposure to cannabis at least once

排除标准

  • Pregnancy

研究组 & 干预措施

THC

Active Comparator
  • High dose: 0.036 mg/kg (2.5 mg in a 70 kg individual) IV (in the vein) dissolved in ethanol.Equivalent to smoking a full joint
  • Low dose: 0.018 mg/kg (1.25 mg in a 70kg individual)IV (in the vein) dissolved in ethanol.Equivalent to smoking ½ of a joint
  • Very low dose: 0.0036 mg/kg (0.25 mg in a 70 kg individual)IV (in the vein) dissolved in ethanol.Equivalent to smoking 1/10 of a joint

干预措施: THC (Drug)

Placebo

Placebo Comparator

Placebo: Small amount of ethanol IV (in the vein), (quarter teaspoon).

干预措施: Placebo (Drug)

结局指标

主要结局

Clinician Administered Dissociative Symptoms Scale, Visual Analog Scale ("High" rating), Rey Auditory Verbal Learning Test

时间窗: Baseline, +15, +25 (RAVLT only), +70, +240

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Deepak C. D'Souza

Professor

Yale University

研究点 (1)

Loading locations...

相似试验